In this interview, News-Medical talks to Dr. Shuang Zhou about cytokine-base cancer immunotherapy, the current state of the field, and future prospects. Cytokines are molecular messengers released by ...

Cancer immunotherapy has advanced significantly in recent years, dramatically improving patient prognosis and survival. The majority of cancer immunotherapy research currently focuses on the first T ...

Cytokines are small proteins that enable cells to communicate with each other, particularly to modulate the immune system—an increasingly popular target in drug development for immunology, virology, ...

A recent review examined natural killer–based therapies, a type of immunotherapy that holds promise for treating leukemia with less toxicity than currently available therapies. Although chemotherapy ...

Scientists rely on cytokines, growth factors, and other agents to direct and create different types of organoid models.

The job of your immune system is to protect your body from harmful foreign substances and keep you healthy. But sometimes your immune system does your body more harm than good. A cytokine storm occurs ...

FHAB platform is the foundation of a modular, plug-and-play construct for potentiating a range of large molecule therapeutic classes, including cytokines, peptides, antibodies and vaccines. Sonnet’s ...